Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of Disease
Open Access
- 1 December 2016
- journal article
- review article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 1 (2), 79-86
- https://doi.org/10.14218/jcth.2013.00015
Abstract
JCTH,Journal of Clinical and Translational HepatologyKeywords
This publication has 99 references indexed in Scilit:
- Pathological roles of purinergic signaling in the liverJournal of Hepatology, 2012
- Making sense of regulatory T cell suppressive functionSeminars in Immunology, 2011
- Interleukin-17 Contributes to the Pathogenesis of Autoimmune Hepatitis through Inducing Hepatic Interleukin-6 ExpressionPLOS ONE, 2011
- CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple SclerosisThe Journal of Immunology, 2009
- CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel diseaseProceedings of the National Academy of Sciences of the United States of America, 2009
- Identification of CD4 T-Cell Epitopes in Soluble Liver Antigen/Liver Pancreas Autoantigen in Autoimmune HepatitisGastroenterology, 2008
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseasesNature Reviews Drug Discovery, 2008
- Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitisJournal of Hepatology, 2008
- Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppressionThe Journal of Experimental Medicine, 2007
- CD39 and control of cellular immune responsesPurinergic Signalling, 2007